Literature DB >> 19804412

The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.

Anja Hauburger1, Sabrina von Einem, Gerburg K Schwaerzer, Anja Buttstedt, Matthias Zebisch, Michael Schräml, Peter Hortschansky, Petra Knaus, Elisabeth Schwarz.   

Abstract

Pro-forms of growth factors have received increasing attention since it was shown that they can affect both the maturation and functions of mature growth factors. Here, we assessed the biological function of the pro-form of bone morphogenetic protein-2 (BMP-2), a member of the transforming growth factor beta (TGFbeta)/BMP superfamily. The role of the 263 amino acids of the pro-peptide is currently unclear. In order to obtain an insight into the function of the pro-form (proBMP-2), the ability of proBMP-2 to induce alkaline phosphatase (AP), a marker enzyme for cells differentiating into osteoblasts, was tested. Interestingly, in contrast to mature BMP-2, proBMP-2 did not lead to induction of AP. Instead, proBMP-2 inhibited the induction of AP by BMP-2. This result raised the question of whether proBMP-2 may compete with mature BMP-2 for receptor binding. ProBMP-2 was found to bind to the purified extracellular ligand binding domain (ECD) of BMPR-IA, a high-affinity receptor for mature BMP-2, with a similar affinity as mature BMP-2. Binding of proBMP-2 to BMPR-IA was confirmed in cell culture by cross-linking proBMP-2 to BMPR-IA presented on the cell surface. In contrast to this finding, proBMP-2 did not bind to the ECD of BMPR-II. ProBMP-2 also differed from BMP-2 in its capacity to induce p38 and Smad phosphorylation. The data presented here suggest that the pro-domain of BMP-2 can alter the signalling properties of the growth factor by modulating the ability of the mature part to interact with the receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804412     DOI: 10.1111/j.1742-4658.2009.07361.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.

Authors:  Nathalie di Clemente; Soazik P Jamin; Alexey Lugovskoy; Paul Carmillo; Christian Ehrenfels; Jean-Yves Picard; Adrian Whitty; Nathalie Josso; R Blake Pepinsky; Richard L Cate
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 2.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

3.  A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Authors:  Takuya Akiyama; Guillermo Marqués; Kristi A Wharton
Journal:  Sci Signal       Date:  2012-04-03       Impact factor: 8.192

Review 4.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

5.  Association between expression of the bone morphogenetic proteins 2 and 7 in the repair of circumscribed cartilage lesions with clinical outcome.

Authors:  Hagen Schmal; Philipp Niemeyer; Jörn Zwingmann; Fabian Stoffel; Norbert P Südkamp; Alexander T Mehlhorn
Journal:  BMC Musculoskelet Disord       Date:  2010-07-29       Impact factor: 2.362

6.  Secondary structure of rhBMP-2 in a protective biopolymeric carrier material.

Authors:  Flora Gilde; Ofélia Maniti; Raphael Guillot; Joao F Mano; Delphine Logeart-Avramoglou; Frédéric Sailhan; Catherine Picart
Journal:  Biomacromolecules       Date:  2012-10-01       Impact factor: 6.988

7.  The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Elfie Kathrin Roedel; Elisabeth Schwarz; Sandip Madhav Kanse
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

8.  Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.

Authors:  Yvonne Kienast; Ute Jucknischke; Stefan Scheiblich; Martina Thier; Mariana de Wouters; Alexander Haas; Christian Lehmann; Verena Brand; Dirk Bernicke; Konrad Honold; Stefan Lorenz
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

9.  Different requirements for proteolytic processing of bone morphogenetic protein 5/6/7/8 ligands in Drosophila melanogaster.

Authors:  Cornelia Fritsch; Annick Sawala; Robin Harris; Aidan Maartens; Catherine Sutcliffe; Hilary L Ashe; Robert P Ray
Journal:  J Biol Chem       Date:  2011-12-23       Impact factor: 5.157

Review 10.  The biological function of type I receptors of bone morphogenetic protein in bone.

Authors:  Shuxian Lin; Kathy K H Svoboda; Jian Q Feng; Xinquan Jiang
Journal:  Bone Res       Date:  2016-04-05       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.